Regulation of vascular endothelial growth factor binding and activity by extracellular pH

被引:56
作者
Goerges, AL [1 ]
Nugent, MA [1 ]
机构
[1] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA
关键词
D O I
10.1074/jbc.M211208200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Angiogenesis, the growth of new blood vessels, is regulated by a number of factors, including hypoxia and vascular endothelial growth factor ( VEGF). Although the effects of hypoxia have been studied intensely, less attention has been given to other extracellular parameters such as pH. Thus, the present study investigates the consequences of acidic pH on VEGF binding and activity in endothelial cell cultures. We found that the binding of VEGF(165) and VEGF(121) to endothelial cells increased as the extracellular pH was decreased from 7.5 to 5.5. Binding of VEGF(165) and VEGF(121) to endothelial extracellular matrix was also increased at acidic pH. These effects were, in part, a reflection of increased heparin binding, because VEGF(165) and VEGF(121) showed increased retention on heparin-Sepharose at pH 5.5 compared with pH 7.5. Consistent with these findings, soluble heparin competed for VEGF binding to endothelial cells under acidic conditions. However, at neutral pH ( 7.5) low concentrations of heparin (0.1-1.0 mug/ml) potentiated VEGF binding. Extracellular pH also regulated VEGF activation of the extracellular signal-regulated kinases 1 and 2 (Erk1/2). VEGF(165) and VEGF(121) activation of Erk1/ 2 at pH 7.5 peaked after 5 min, whereas at pH 6.5 the peak was shifted to 10 min. At pH 5.5, neither VEGF isoform was able to activate Erk1/ 2, suggesting that the increased VEGF bound to the cells at low pH was sequestered in a stored state. Therefore, extracellular pH might play an important role in regulating VEGF interactions with cells and the extracellular matrix, which can modulate VEGF activity.
引用
收藏
页码:19518 / 19525
页数:8
相关论文
共 41 条
[11]   Insulin-like growth factor (IGF) binding protein-3 regulation of IGF-I is altered in an acidic extracellular environment [J].
Forsten, KE ;
Akers, RM ;
San Antonio, JD .
JOURNAL OF CELLULAR PHYSIOLOGY, 2001, 189 (03) :356-365
[12]   Glypican-1 is a VEGF165 binding proteoglycan that acts as an extracellular chaperone for VEGF165 [J].
Gengrinovitch, S ;
Berman, B ;
David, G ;
Witte, L ;
Neufeld, G ;
Ron, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (16) :10816-10822
[13]   Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes - Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia [J].
Gerber, HP ;
Condorelli, F ;
Park, J ;
Ferrara, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (38) :23659-23667
[14]  
GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093
[15]   Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena [J].
Iozzo, RV ;
San Antonio, JD .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (03) :349-355
[16]   The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency [J].
Keyt, BA ;
Berleau, LT ;
Nguyen, HV ;
Chen, H ;
Heinsohn, H ;
Vandlen, R ;
Ferrara, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (13) :7788-7795
[17]   The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer [J].
Kleeff, J ;
Ishiwata, T ;
Kumbasar, A ;
Friess, H ;
Buchler, MW ;
Lander, AD ;
Korc, M .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (09) :1662-1673
[18]   METABOLISM OF RECEPTOR-BOUND AND MATRIX-BOUND BASIC FIBROBLAST GROWTH-FACTOR BY BOVINE CAPILLARY ENDOTHELIAL-CELLS [J].
MOSCATELLI, D .
JOURNAL OF CELL BIOLOGY, 1988, 107 (02) :753-759
[19]   KINETICS OF BASIC FIBROBLAST GROWTH-FACTOR BINDING TO ITS RECEPTOR AND HEPARAN-SULFATE PROTEOGLYCAN - A MECHANISM FOR COOPERATIVITY [J].
NUGENT, MA ;
EDELMAN, ER .
BIOCHEMISTRY, 1992, 31 (37) :8876-8883
[20]   Fibroblast growth factor-2 [J].
Nugent, MA ;
Iozzo, RV .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2000, 32 (02) :115-120